When calprotectin was combined with established melanoma biomarkers S100B and lactate dehydrogenase (LDH), the model’s diagnostic performance improved, with a combined AUC of 0.755 (95% CI: 0.684–0.827), as illustrated in Figure 1B. Here, S100B is linked to melanoma.